M

Magnet Biomedicine

Develops small-molecule molecular glue therapeutics

Senior Scientist - Computational Chemistry

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$145k - $185kIn-person

About the Job

Requirements

  • A Ph.D. in Computational Chemistry, Cheminformatics, Chemistry, Computer Science, Data Science, or a related field, with 5–8 years of experience in life sciences; or an equivalent combination of education and experience.
  • A track record of publications, patents, and conference presentations in drug discovery.
  • Proficiency in ligand-based and structure-based drug design approaches, including docking, reaction enumeration, pharmacophore hypothesis generation, molecular dynamics, and free-energy perturbation, to enable hypothesis-driven compound design and library synthesis.
  • Hands-on experience with Vortex, Schrödinger Suite, MOE, AMBER, and open-source tools.
  • A solid understanding of medicinal chemistry design principles and project data in drug discovery.
  • A demonstrated track record of independently generating and proposing original compound design ideas, including new scaffolds, substituents, linkers, and optimization strategies.
  • Demonstrated partnership with medicinal chemists and biologists across iterative design-make-test-analyze cycles.
  • Excellent written and verbal communication skills, with the ability to present complex scientific concepts to diverse audiences.

Responsibilities

  • Apply ligand-based and structure-based drug design approaches, including molecular dynamics simulation, TI/FEP+, water analysis, and protein dynamics, to enable hypothesis-driven compound design and reaction-based library design.
  • Partner with medicinal chemists, biologists, biophysicists, protein scientists, proteomics, DMPK, and informatics teams to support early discovery and pipeline programs.
  • Apply medicinal chemistry design principles, including structure-activity relationships, potency and property balance, ADMET, selectivity, and synthetic feasibility, to prioritize and refine computational designs.
  • Communicate findings to technical and non-technical audiences across all levels of the organization.
  • Build and maintain computational tools, workflows, AI/ML models, and databases for processing and analyzing drug discovery datasets, including DNA-encoded library data analysis and construction, druggability evaluation, target/presenter gluability, and ADMET prediction.
  • Analyze and interpret experimental data, including ternary and binary biochemical, biophysical, and cellular assay data; X-ray and cryo-electron microscopy structures; XL-MS/HDX/NMR; DNA-encoded library data; and proteomics screening, to generate insights that guide project decisions and the design-make-test-analyze cycle.
  • Drive development and implementation of computational methodologies, including AI/ML, data exploration, and visualization, to strengthen and expand the molecular glue discovery platform.
  • Manage and maintain R&D software platforms, including Vortex, Schrödinger Suite (Maestro, LiveDesign, PyMOL), MOE, and RESTful APIs.

Desired Qualifications

  • Experience with molecular glues, PROTACs, DNA-encoded library data analysis, RIPTACs, or other heterobifunctional degrader or non-degrader modalities.
  • Familiarity with cheminformatics, Agentic AI, explainable AI (xAI), and generative AI such as REINVENT and LibINVENT.
  • Experience building scalable research infrastructure with automation, good design patterns, and reusability in mind.

About the Company

Magnet Biomedicine

Develops small-molecule molecular glue therapeutics

Magnet Biomedicine builds small-molecule therapeutics called molecular glues that modulate protein–protein interactions to address targets that are hard to drug. Its TrueGlue platform uses proprietary chemical libraries and human biology to select targets and design glues that recruit a presenter protein to a disease-relevant target, altering function or stability rather than simply degrading it. The company differentiates itself by aiming for tissue-specific effects and a broader range of outcomes beyond degradation, backed by chemistry-driven discovery and strong industry partnerships. Its goal is to bring novel medicines to patients, focusing on oncology, cardiovascular disease, and immune disorders, with collaborations like the Lilly deal to accelerate development and commercialization.

Company size
11-50
Company stage
Series A
Total funding
$50M
Headquarters
Boston, MA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Magnet Biomedicine

See more jobs